Quantum-si Inc (QSI)
$1.51
+0.01
(+0.67%)▲
Live
Insights on Quantum-si Inc
Vs NVO
In the last 1 year, Novo Nordisk A/s has given 72.6% return, outperforming this stock by 83.8%
Vs NVO
In the last 3 years, Novo Nordisk A/s has given 235.1% return, outperforming this stock by 320.1%
Performance
- $1.47$1.51$1.51
2.65%
Downside
Day's Volatility :2.65%
Upside
0.0%
- $1.12$3.90$1.51
25.83%
Downside
52 Weeks Volatility :71.28%
Upside
61.28%
Returns
| Period | Quantum-si Inc | Sector (Health Care) | Index (Russel 2000) |
|---|---|---|---|
3 Months | -18.92% | -1.0% | 0.0% |
6 Months | -14.77% | 9.6% | 0.0% |
1 Year | -9.64% | 11.0% | 0.0% |
3 Years | -84.98% | 18.5% | -22.6% |
Highlights
Market Capitalization | 220.5M |
Book Value | $1.79 |
Earnings Per Share (EPS) | -0.65 |
Wall Street Target Price | 2.75 |
Profit Margin | 0.0% |
Operating Margin TTM | -5111.6% |
Return On Assets TTM | -19.67% |
Return On Equity TTM | -30.98% |
Revenue TTM | 1.3M |
Revenue Per Share TTM | 0.01 |
Quarterly Revenue Growth YOY | 79.9% |
Gross Profit TTM | 0.0 |
EBITDA | -96.4M |
Diluted Eps TTM | -0.65 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -0.74 |
EPS Estimate Next Year | -0.83 |
EPS Estimate Current Quarter | -0.2 |
EPS Estimate Next Quarter | -0.2 |
Analyst Recommendation
- Current
- 1M Ago
- 3M Ago
Analyst Forecast
What analysts predicted
Upside of 82.12%
Technicals Summary
Sell
Neutral
Buy
Quantum-si Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
 Quantum-si Inc | -18.48% | -14.77% | -9.64% | -84.98% | -84.82% |
 Moderna, Inc. | 21.03% | 85.08% | 14.68% | -28.27% | 659.22% |
 Regeneron Pharmaceuticals, Inc. | 3.22% | 20.18% | 31.88% | 93.3% | 227.58% |
 Novo Nordisk A/s | 8.85% | 34.38% | 71.83% | 235.07% | 463.44% |
 Vertex Pharmaceuticals Incorporated | 16.81% | 34.1% | 40.6% | 123.97% | 174.53% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
Quantum-si Inc | 3.1 | NA | NA | -0.74 | -0.31 | -0.2 | NA | 1.79 |
Moderna, Inc. | 24.73 | NA | 0.0 | -7.14 | -0.38 | -0.16 | NA | 33.47 |
Regeneron Pharmaceuticals, Inc. | 28.89 | 28.89 | 1.46 | 44.13 | 0.15 | 0.08 | NA | 250.15 |
Novo Nordisk A/s | 46.97 | 46.97 | 2.36 | 3.5 | 1.0 | 0.25 | 0.01 | 22.18 |
Vertex Pharmaceuticals Incorporated | 29.59 | 29.59 | 0.53 | 17.08 | 0.24 | 0.13 | NA | 71.8 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
Quantum-si Inc | Buy | $220.5M | -84.82% | 3.1 | 0.0% |
Moderna, Inc. | Buy | $54.6B | 659.22% | 24.73 | -115.82% |
Regeneron Pharmaceuticals, Inc. | Buy | $108.0B | 227.58% | 28.89 | 29.45% |
Novo Nordisk A/s | Buy | $602.6B | 463.44% | 46.97 | 36.55% |
Vertex Pharmaceuticals Incorporated | Buy | $117.5B | 174.53% | 29.59 | 39.46% |
Institutional Holdings
ARK Investment Management LLC
9.00%Sumitomo Mitsui Trust Holdings Inc
5.68%Nikko Asset Management Americas Inc
5.68%BlackRock Inc
5.10%Vanguard Group Inc
3.74%State Street Corporation
1.52%
Company Information
at quantum-si we have a created a very unique environment where bright, highly committed individuals are given the freedom, ownership, and resources to solve tough problems and be the first to do new science. we are fully-funded by successful founders so employees can focus on creating, building, learning, and getting to market products that will change the world. if you are looking for a new challenge, check out our job postings at https://www.4catalyzer.com empower discovery. empower health. empower you.
Organization | Quantum-si Inc |
Employees | 159 |
CEO | Dr. Jonathan M. Rothberg Ph.D. |
Industry | Technology |
